Regulation of Fas receptor/Fas-asssociated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease

(2009) David A. Price et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: Compound-specific and area-specific distribution within the brain

(2009) I. Barna et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: Role of PEA-15 as a FADD-ERK binding partner in striatal plasticity

(2009) Alfredo Ramos-Miguel et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway

(2009) M. T. Viscomi et al.   JOURNAL OF NEUROSCIENCE

The Fas–FADD death domain complex structure unravels signalling by receptor clustering

(2009) Fiona L. Scott et al.   NATURE

Mitochondrial membrane permeabilization in neuronal injury

(2009) Lorenzo Galluzzi et al.   NATURE REVIEWS NEUROSCIENCE

Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: Relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity

(2009) A. Ramos-Miguel et al.   NEUROSCIENCE

Mechanisms of Control of Neuron Survival by the Endocannabinoid System

(2008) Ismael Galve-Roperh et al.   CURRENT PHARMACEUTICAL DESIGN

P.1.c.019 Regulation of pro-apoptotic Fas/FADD protein complex in brain regions of CB1-receptor deficient mice

(2008) M. Álvaro-Bartolomé et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors

(2008) Meritxell Canals et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: Functional interactions with casein kinase Iα, Gαi proteins, and ERK1/2 signaling

(2008) M. Julia García-Fuster et al.   NEUROPHARMACOLOGY

Effect of Cocaine on Fas-Associated Protein with Death Domain in the Rat Brain: Individual Differences in a Model of Differential Vulnerability to Drug Abuse

(2008) María-Julia García-Fuster et al.   NEUROPSYCHOPHARMACOLOGY

Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers

(2008) M.J. García-Fuster et al.   NEUROSCIENCE

Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI

(2007) C-L Chin et al.   BRITISH JOURNAL OF PHARMACOLOGY

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour

(2007) T. Rubino et al.   NEUROPHARMACOLOGY